Qualification of a Multiplexed Tissue Imaging Assay and Detection of Novel Patterns of HER2 Heterogeneity in Breast Cancer

Researchers qualified a breast cancer-specific antibody panel, including HER2, ER, and PR, for multiplexed tissue imaging. They then compared the performance of these antibodies against established clinical standards using pixel-, cell- and tissue-level analyses, utilizing 866 tissue cores